Subscribe to RSS
DOI: 10.1055/s-0040-1708486
Use of Extracorporeal Membrane Oxygenation for Major Cardiopulmonary Resections
Funding None.![](https://www.thieme-connect.de/media/thoracic/202103/lookinside/thumbnails/10-1055-s-0040-1708486_195753ot-1.jpg)
Abstract
Background In thoracic surgery, utilization of extracorporeal membrane oxygenation (ECMO) is mainly established for patients undergoing lung transplantation. The aim of our study was to summarize our single-center experience with intraoperative use of veno-venous- or veno-arterial-ECMO in patients undergoing complex lung surgery involving the main carina, or the left atrium or the descending aorta.
Methods A total of 24 patients underwent combined complex lung, carinal, aortal, or left atrial resections. In cases of carinal resection, percutaneous veno-venous, jugular–femoral cannulation was considered suitable. For combined resection of lung and descending aorta, a percutaneous femoral veno-arterial cannulation was used. In cases of extended left atrial resection, a percutaneous jugular–femoral veno-venous-arterial cannulation was favored.
Results Procedures were divided into three groups: carinal resections and reconstruction (n = 8), resections of the descending aorta and left lung (n = 7), resections of lung and left atrium (n = 9). No intraoperative complications occurred. Overall 30-day mortality was 25%. A complete resection was achieved in 18 patients. Median survival was 12 months. One- and 5-year survival were 48.1 and 22.7%, respectively.
Conclusion The present study shows that intraoperative use of ECMO for extended carinal, aortic, or atrial resections is feasible with minimal intraoperative complications allowing surgeons increased operating-field safety. Perioperative mortality is high, but this is rather an attribute of local extended disease and patient comorbidities.
Publication History
Received: 24 November 2019
Accepted: 27 January 2020
Article published online:
08 April 2020
© 2020. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Combes A, Hajage D, Capellier G. et al; EOLIA Trial Group, REVA, and ECMONet. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med 2018; 378 (21) 1965-1975
- 2 McRae K, de Perrot M. Principles and indications of extracorporeal life support in general thoracic surgery. J Thorac Dis 2018; 10 (Suppl 8): S931-S946
- 3 Fan E, Karagiannidis C. Less is more: not (always) simple-the case of extracorporeal devices in critical care. Intensive Care Med 2019; 45 (10) 1451-1453
- 4 Combes A, Bréchot N, Luyt CE, Schmidt M. Indications for extracorporeal support: why do we need the results of the EOLIA trial?. Med Klin Intensivmed Notf Med 2018; 113 (Suppl 1): 21-25
- 5 Biscotti M, Gannon WD, Agerstrand C. et al. Awake extracorporeal membrane oxygenation as bridge to lung transplantation: a 9-year experience. Ann Thorac Surg 2017; 104 (02) 412-419
- 6 Hoechter DJ, Shen YM, Kammerer T. et al. Extracorporeal circulation during lung transplantation procedures: a meta-analysis. ASAIO J 2017; 63 (05) 551-561
- 7 Dartevelle PG, Mitilian D, Fadel E. Extended surgery for T4 lung cancer: a 30 years' experience. Gen Thorac Cardiovasc Surg 2017; 65 (06) 321-328
- 8 Kelly B, Carton E. Extended indications for extracorporeal membrane oxygenation in the operating room. J Intensive Care Med 2020; 35 (01) 24-33
- 9 Biscotti M, Yang J, Sonett J, Bacchetta M. Comparison of extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation. J Thorac Cardiovasc Surg 2014; 148 (05) 2410-2415
- 10 Machuca TN, Collaud S, Mercier O. et al. Outcomes of intraoperative extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation. J Thorac Cardiovasc Surg 2015; 149 (04) 1152-1157
- 11 Lang G, Ghanim B, Hötzenecker K. et al. Extracorporeal membrane oxygenation support for complex tracheo-bronchial procedures. Eur J Cardiothorac Surg 2015; 47 (02) 250-255 , discussion 256
- 12 Kim CW, Kim DH, Son BS. et al. The feasibility of extracorporeal membrane oxygenation in the variant airway problems. Ann Thorac Cardiovasc Surg 2015; 21 (06) 517-522
- 13 Byrne JG, Leacche M, Agnihotri AK. et al. The use of cardiopulmonary bypass during resection of locally advanced thoracic malignancies: a 10-year two-center experience. Chest 2004; 125 (04) 1581-1586
- 14 Ohta M, Hirabayasi H, Shiono H. et al. Surgical resection for lung cancer with infiltration of the thoracic aorta. J Thorac Cardiovasc Surg 2005; 129 (04) 804-808
- 15 Marulli G, Rendina EA, Klepetko W. et al. Surgery for T4 lung cancer invading the thoracic aorta: do we push the limits?. J Surg Oncol 2017; 116 (08) 1141-1149
- 16 Galvaing G, Tardy MM, Cassagnes L. et al. Left atrial resection for T4 lung cancer without cardiopulmonary bypass: technical aspects and outcomes. Ann Thorac Surg 2014; 97 (05) 1708-1713
- 17 Fukuse T, Wada H, Hitomi S. Extended operation for non-small cell lung cancer invading great vessels and left atrium. Eur J Cardiothorac Surg 1997; 11 (04) 664-669
- 18 Ratto GB, Costa R, Vassallo G, Alloisio A, Maineri P, Bruzzi P. Twelve-year experience with left atrial resection in the treatment of non-small cell lung cancer. Ann Thorac Surg 2004; 78 (01) 234-237
- 19 Antonia SJ, Villegas A, Daniel D. et al; PACIFIC Investigators. Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. N Engl J Med 2017; 377 (20) 1919-1929
- 20 Rinieri P, Peillon C, Bessou JP. et al. National review of use of extracorporeal membrane oxygenation as respiratory support in thoracic surgery excluding lung transplantation. Eur J Cardiothorac Surg 2015; 47 (01) 87-94